Faculty Profiles - MASUYAMA Hisashi

Papers - MASUYAMA Hisashi

Division display 621 - 640 of about 762 ／ All the affair displays >>

藤田志保, 長谷川徹, 西山悠紀, 藤澤諭, 細谷武史, 岩田菜穂子, 鎌田泰彦, 増山寿, 大塚文男

日本内分泌学会雑誌 94 ( 1 ) 369 - 369 2018.4

Prognostic nutritional index as a predictor of survival in patients with recurrent cervical cancer. Reviewed International journal

Ida N, Nakamura K, Saijo M, Kusumoto T, Masuyama H

Molecular and clinical oncology 8 ( 2 ) 257 - 263 2018.2

Language：English Publishing type：Research paper (scientific journal) Publisher：SPANDIDOS PUBL LTD

Systemic inflammatory responses (SIRs) can help predict survival in various cancers. The present study investigated the accuracy of neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR) and prognostic nutritional index (PNI) in predicting survival for patients with recurrent cervical cancer. A retrospective review of prognoses examined the associations among NLR, PLR, and PNI, and clinical characteristics and survival in 79 patients with recurrent cervical cancer after undergoing concurrent chemoradiation therapy (CCRT) or radical hysterectomies with or without CCRT. The Mann-Whitney U-test was used for statistical analyses. In addition, 12-month, 24-month and overall survival were analyzed by the Kaplan-Meier method. Cox's proportional hazard regression was used for univariate and multivariate analyses. Median survival was 15.0 months over follow-up periods of 2-93 months. At the last follow-up point, 54 had succumbed to disease and 25 were alive with disease. In univariate analysis, NLR, PLR and PNI were significantly associated with 12-month, 24 month and overall survival (12 months: P=0.021, P=0.001 and P<0.001; 24 months: P=0.020, P=0.008 and P<0.001; overall; P=0.032, P=0.032 and P<0.001, respectively). In multivariate analyses, PNI was an independent prognostic factor for 12-month, 24-month and overall survival (P=0.001, P=0.001 and P<0.001, respectively). PNI is a useful predictor of survival of recurrent cervical cancer.

DOI： 10.3892/mco.2017.1508

Web of Science

PubMed

researchmap

静脈血栓塞栓症(VTE)予防における分娩後抗凝固療法の有用性は,D-dimer値で評価可能か

早田桂, 谷和祐, 牧尉太, 江口武志, 玉田祥子, 光井崇, 衛藤英理子, 増山寿

日本産科婦人科学会雑誌 70 ( 2 ) 796 - 796 2018.2

初期子宮体癌低侵襲手術における術式に関する検討

楠本知行, 依田尚之, 西條昌之, 西田傑, 原賀順子, 小川千加子, 中村圭一郎, 増山寿

日本産科婦人科学会雑誌 70 ( 2 ) 764 - 764 2018.2

再発リスクを有する子宮体癌において,POLE変異/MSIは予後良好因子である

原賀順子, 永坂岳司, 春間朋子, 西田傑, 中村圭一郎, 増山寿

日本産科婦人科学会雑誌 70 ( 2 ) 646 - 646 2018.2

子宮体癌における遺伝子変異やメチル化変異の検討

西田傑, 中村圭一郎, 原賀順子, 西條昌之, 依田尚之, 小川千加子, 楠本知行, 増山寿

日本産科婦人科学会雑誌 70 ( 2 ) 655 - 655 2018.2

腹式広汎子宮頸部摘出術後に自然妊娠し,妊娠初期に経腹的頸管縫縮術を施行した一例

光井崇, 谷和祐, 牧尉太, 江口武志, 玉田祥子, 衛藤英理子, 早田桂, 増山寿

日本産科婦人科学会雑誌 70 ( 2 ) 1035 - 1035 2018.2

岡山県におけるがん生殖医療の取り組みがんと生殖医療ネットワークOKAYAMA

酒本あい, 鎌田泰彦, 増山寿, 羽原俊宏, 林伸旨, 藤井伸治, 枝園忠彦, 中塚幹也

日本がん・生殖医療学会誌 1 ( 1 ) 105 - 105 2018.2

婦人科悪性腫瘍手術後患者における大建中湯の有用性

藤田志保, 関典子, 西條昌之, 依田尚之, 大道千晶, 原賀順子, 西田傑, 小川千加子, 楠本知行, 鎌田泰彦, 中村圭一郎, 増山寿

日本産科婦人科学会雑誌 70 ( 2 ) 968 - 968 2018.2

帝王切開時筋腫核出術を施行した36例の検討

谷村吏香, 衛藤英理子, 牧尉太, 玉田祥子, 光井崇, 早田桂, 増山寿

日本産科婦人科学会雑誌 70 ( 2 ) 973 - 973 2018.2

胎児期に心臓に高エコー域を認め出生後Fetal cardiac calcificationと診断された1例

谷和祐, 牧尉太, 江口武志, 玉田祥子, 光井崇, 衛藤英理子, 早田桂, 増山寿

日本産科婦人科学会雑誌 70 ( 2 ) 913 - 913 2018.2

サルコペニアは同時化学放射線療法を施行した子宮頸癌患者の予後不良因子になる

清時毅典, 中村圭一郎, 依田尚之, 西條昌之, 大道千晶, 原賀順子, 西田傑, 小川千加子, 楠本知行, 増山寿

日本産科婦人科学会雑誌 70 ( 2 ) 948 - 948 2018.2

当院での悪性腫瘍手術における希釈式自己血輸血の現状

大平安希子, 原賀順子, 関典子, 依田尚之, 西條昌之, 大道千晶, 西田傑, 小川千加子, 楠本知行, 中村圭一郎, 増山寿

日本産科婦人科学会雑誌 70 ( 2 ) 776 - 776 2018.2

Sarcopenia is an important prognostic factor in patients with cervical cancer undergoing concurrent chemoradiotherapy Reviewed

Takanori Kiyotoki, Keiichiro Nakamura, Junko Haraga, Chiaki Omichi, Naoyuki Ida, Masayuki Saijo, Takeshi Nishida, Tomoyuki Kusumoto, Hisashi Masuyama

International Journal of Gynecological Cancer 28 ( 1 ) 168 - 175 2018.1

Language：English Publishing type：Research paper (scientific journal) Publisher：Lippincott Williams and Wilkins

Objective This study aimed to investigate the correlation of sarcopenia findings with prognostic factors in patients with cervical cancer (CC) undergoing concurrent chemoradiotherapy (CCRT). Methods We retrospectively collected data on body composition and clinicopathological features from the medical records of 60 patients with CC who underwent CCRT and analyzed correlations between prognosis and changes in body composition as measured by computed tomography (skeletal muscle and iliopsoas muscle [IM]). Statistical analyses were performed using the Mann-Whitney U test. Progression-free survival (PFS) and overall survival (OS) were analyzed using the Kaplan-Meier method. Cox proportional hazard regression was used for univariate and multivariate analyses. Results The median follow-up for all patients who were alive at the last follow-up was 33.5 months (range, 1-104 months). The PFS and OS rates were worse for patients with at least 15.0% than for those with less than 15.0% loss of skeletal muscle and IM from baseline (P &lt
0.001 for both). Furthermore, multivariate analyses showed that at least 15.0% loss of IM was an independent prognostic factor for PFS and OS (P = 0.002 for both). Conclusions Sarcopenia (≥15.0% loss of IM from baseline) was revealed to be an important prognostic factor in patients with CC undergoing CCRT.

DOI： 10.1097/IGC.0000000000001127

常位胎盤早期剥離の搬送、システム常位胎盤早期剥離の搬送体制改善に向けた院内改革と県下の現状搬送システムOKAYAMA Perinatal Integrated Conveying Sheet System"Okayama Picss"の構築 Reviewed

牧尉太, 早田桂, 玉田祥子, 江口武志, 光井崇, 衛藤英理子, 平松裕司, 増山寿

日本周産期・新生児医学会雑誌 53 ( 別冊 ) 32 - 33 2018.1